⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Ventas VTR

United States Real Estate
4.6/10
AI Analyst score
86.59 USD
Last price at analysis date · analyst target 101.82 (+17.6%)
🛒 Where to buy VTRPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold; rising rates and an unsustainable payout limit the appeal despite good momentum and revenue growth.

Ventas, Inc. is a real estate investment trust (REIT) that owns and operates healthcare properties, primarily senior housing communities and research and life science centers. Ventas shows strong revenue growth (21.7%) and exceptional momentum (8.48), but its financial health is strained by net debt of 5.34x EBITDA and a payout of 363%, making its 2.4% dividend unsustainable at current levels.

Financial health
5.8
Quality / Moat
4.0
Valuation
3.5
Growth
6.3
Dividend
1.2
Momentum
8.5
Risk & Context
7.1

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E157.44
Fwd P/E109.61
EV/EBITDA24.23
P/B3.03
P/S6.92
PEG4.94
Market cap44.42 B USD
Enterprise value57.70 B USD
🏰 Quality and moat
ROIC (approx.)3.5%
Gross margin39.97%
FCF conversion62%
Operating margin14.81%
📈 Profitability and margins
ROE2.01%
ROA2.17%
Net margin4.09%
FCF1.49 B USD
FCF yield3.35%
🏦 Solvency and liquidity
Total debt12.92 B USD
Net debt12.72 B USD
Cash199.0 M USD
EBITDA2.38 B USD
Net debt / EBITDA5.34
D/E84.93
Current ratio0.29
Quick ratio0.26
🚀 Growth
Revenue growth21.70%
Earnings growth-6.70%
EPS (TTM)0.55 USD
EPS (Fwd)0.79 USD
💰 Dividend and risk
Dividend yield2.40%
Payout363.6%
Beta0.72
Analyst consensusBuy (22)
Target price101.82 USD
52-week range66.93 USD – 101.60 USD
⚠️ Main risk: High leverage (Net Debt/EBITDA of 5.34) combined with the rise in 10-year interest rates, which makes refinancing more expensive and pressures the value of its long-duration real estate assets.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Ventas, Inc. is a real estate investment trust (REIT) that owns and operates healthcare properties, primarily senior housing communities and research and life science centers. Ventas shows strong revenue growth (21.7%) and exceptional momentum (8.48), but its financial health is strained by net debt of 5.34x EBITDA and a payout of 363%, making its 2.4% dividend unsustainable at current levels.

Score by category

CategoryScore
Financial health5.8
Quality / Moat4.0
Valuation3.5
Growth6.3
Dividend1.2
Momentum8.5
Risk & Context7.1

OVERALL SCORE: 4.6/10

Context and risks

Healthcare REIT with Net Debt/EBITDA of 5.34, highly leveraged. The rise in 10-year rates to 5.17% makes refinancing its debt more expensive and pressures the value of its long-duration assets, a material risk to its balance sheet.

News considered in the analysis

  • 4 Senior Housing REITs Betting Big on America’s Aging Population — Refuerza la tesis de demanda estructural a largo plazo para el segmento de vivienda para mayores, pero es un tema ampliamente conocido y ya descontado en el momentum de la acción.
  • Despite Sale, Baron Capital Maintains Outlook on Ventas (VTR) — Ruido de mercado sin información nueva sobre los fundamentales de la empresa.
  • Ventas (VTR) Stock May Trade At A Discount Following Its 124% Run — Opinión de análisis sobre valoración relativa tras la fuerte subida; no es un hecho material nuevo.
  • Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio — Artículo promocional genérico; no aporta información nueva.
  • Ventas Stock: Is VTR Outperforming the Real Estate Sector? — Comparativa de rendimiento bursátil sin implicación directa para beneficios futuros.

Verdict: Hold; rising rates and an unsustainable payout limit the appeal despite good momentum and revenue growth.

Main risk: High leverage (Net Debt/EBITDA of 5.34) combined with the rise in 10-year interest rates, which makes refinancing more expensive and pressures the value of its long-duration real estate assets.

Other Real Estate companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.